These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16956955)

  • 1. Identification of binding sites of non-I-helix water molecules in mammalian cytochromes p450.
    Locuson CW; Tracy TS
    Drug Metab Dispos; 2006 Dec; 34(12):1954-7. PubMed ID: 16956955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450.
    Clodfelter KH; Waxman DJ; Vajda S
    Biochemistry; 2006 Aug; 45(31):9393-407. PubMed ID: 16878974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of water molecules in the active-site cavity of human cytochromes P450.
    Rydberg P; Rod TH; Olsen L; Ryde U
    J Phys Chem B; 2007 May; 111(19):5445-57. PubMed ID: 17441761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of a novel reversible cytochrome P450 spectral intermediate: role of threonine 303 in P450 2E1 inactivation.
    Blobaum AL; Lu Y; Kent UM; Wang S; Hollenberg PF
    Biochemistry; 2004 Sep; 43(38):11942-52. PubMed ID: 15379534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
    Kirton SB; Murray CW; Verdonk ML; Taylor RD
    Proteins; 2005 Mar; 58(4):836-44. PubMed ID: 15651036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicoverpa zea CYP6B8 and CYP321A1: different molecular solutions to the problem of metabolizing plant toxins and insecticides.
    Rupasinghe SG; Wen Z; Chiu TL; Schuler MA
    Protein Eng Des Sel; 2007 Dec; 20(12):615-24. PubMed ID: 18065401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
    Hollenberg PF; Kent UM; Bumpus NN
    Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding mode prediction of cytochrome p450 and thymidine kinase protein-ligand complexes by consideration of water and rescoring in automated docking.
    de Graaf C; Pospisil P; Pos W; Folkers G; Vermeulen NP
    J Med Chem; 2005 Apr; 48(7):2308-18. PubMed ID: 15801824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of active site access channels in cytochromes P450.
    Wade RC; Winn PJ; Schlichting I; Sudarko
    J Inorg Biochem; 2004 Jul; 98(7):1175-82. PubMed ID: 15219983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward understanding the inactivation mechanism of monooxygenase P450 BM-3 by organic cosolvents: a molecular dynamics simulation study.
    Roccatano D; Wong TS; Schwaneberg U; Zacharias M
    Biopolymers; 2006 Dec; 83(5):467-76. PubMed ID: 16862534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of cytochrome P450 MoxA from Nonomuraea recticatena (CYP105).
    Yasutake Y; Imoto N; Fujii Y; Fujii T; Arisawa A; Tamura T
    Biochem Biophys Res Commun; 2007 Oct; 361(4):876-82. PubMed ID: 17679139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and dynamic properties of cytochrome P450 BM-3 in pure water and in a dimethylsulfoxide/water mixture.
    Roccatano D; Wong TS; Schwaneberg U; Zacharias M
    Biopolymers; 2005 Aug; 78(5):259-67. PubMed ID: 15880388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Density functional theory (DFT) and combined quantum mechanical/molecular mechanics (QM/MM) studies on the oxygen activation step in nitric oxide synthase enzymes.
    de Visser SP
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):373-7. PubMed ID: 19290865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QM/MM modeling of compound I active species in cytochrome P450, cytochrome C peroxidase, and ascorbate peroxidase.
    Harvey JN; Bathelt CM; Mulholland AJ
    J Comput Chem; 2006 Sep; 27(12):1352-62. PubMed ID: 16788912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
    Masubuchi Y; Horie T
    Crit Rev Toxicol; 2007 Jun; 37(5):389-412. PubMed ID: 17612953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forty years of cytochrome P450.
    Omura T
    Biochem Biophys Res Commun; 1999 Dec; 266(3):690-8. PubMed ID: 10603307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediates in P450 catalysis.
    Poulos TL
    Philos Trans A Math Phys Eng Sci; 2005 Apr; 363(1829):793-806; discussion 1035-40. PubMed ID: 15901536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
    Fasan R; Chen MM; Crook NC; Arnold FH
    Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.